BackCyclo Therapeutics- Warrants (14/11/2025) Overview

Cyclo Therapeutics- Warrants (14/11/2025) Total Assets

Latest total assets for CYTHW: $5.3M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$5.25M
6.13% YoYΔ $-343164.00 vs prior year quarter

Peer average

Loading

Cyclo Therapeutics- Warrants (14/11/2025) Total Assets History

Loading

Cyclo Therapeutics- Warrants (14/11/2025) vs. peers: Total Assets Comparison

Loading

Cyclo Therapeutics- Warrants (14/11/2025) Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cyclo Therapeutics- Warrants (14/11/2025) (CYTHW) FAQ

As of the most recent data (September 2024), CYTHW shows a total assets of $5.3M. That compares with $5.6M in the prior-year period — down 6.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CYTHW's total assets is now $5.3M (was $5.6M) — a 6.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cyclo Therapeutics- Warrants (14/11/2025) is outperforming or lagging.

Tracking CYTHW's total assets over time shows whether Cyclo Therapeutics- Warrants (14/11/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $5.3M That compares with $5.6M in the prior-year period — down 6.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Cyclo Therapeutics- Warrants (14/11/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $5.3M) with ownership activity and broader fundamentals.

Cyclo Therapeutics- Warrants (14/11/2025)'s total assets is $5.3M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.